Sarepta Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine, announced participation in two upcoming virtual investor conferences. The events include the Morgan Stanley Global Healthcare Conference on Sept. 13, 2021, at 1:15 p.m. E.T., and the Cantor Fitzgerald Virtual Global Healthcare Conference on Sept. 27, 2021, at 1:20 p.m. E.T. Live webcasts will be available on Sarepta's website, and the presentations will be archived for 90 days. The company is committed to developing therapies for rare diseases, focusing on Duchenne muscular dystrophy and limb-girdle muscular dystrophies.

CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:

• Morgan Stanley Global Healthcare Conference 2021 on Monday, Sept. 13, at 1:15 p.m. E.T.
• Cantor Fitzgerald Virtual Global Healthcare Conference on Monday, Sept. 27, at 1:20 p.m. E.T.

The presentations will be webcast live on the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com

FAQ

What events will Sarepta Therapeutics participate in September 2021?

Sarepta Therapeutics will participate in the Morgan Stanley Global Healthcare Conference on September 13 and the Cantor Fitzgerald Virtual Global Healthcare Conference on September 27, both in 2021.

What time will the Morgan Stanley Global Healthcare Conference presentation occur?

The Morgan Stanley Global Healthcare Conference presentation is scheduled for September 13, 2021, at 1:15 p.m. E.T.

How can I watch the Sarepta Therapeutics presentations?

You can watch the Sarepta Therapeutics presentations live by visiting their investor relations section on their website.

What is the focus of Sarepta Therapeutics' work?

Sarepta Therapeutics focuses on developing precision genetic medicine for rare diseases, particularly Duchenne muscular dystrophy and limb-girdle muscular dystrophies.

How long will the Sarepta presentations be archived on their website?

The presentations will be archived on Sarepta's website for 90 days after the live events.